Creative Biolabs offers RAW 264.7 cell-based antagonist assays to evaluate anti-inflammatory compounds. Using LPS stimulation, we measure NO, PGE2, and COX-2/iNOS expression, providing precise insights for drug discovery, immune function, and cancer research.
Learn More →Cell-based Antagonist Assay Services
At Creative Biolabs, cell-based antagonist assays meticulously dissect drug interactions within cellular environments, measuring cellular responses to antagonists and providing insights into ligand-receptor interactions, signaling pathways, and downstream cellular events. Our proprietary methodologies leverage advanced technologies like high-content screening and sophisticated imaging systems, offering precise, high-throughput solutions. We engineered our service to eliminate the translational gap from biochemical screens by confirming antagonist binding translates into functional inhibition within a complex physiological context, accounting for cell permeability and off-target effects.
Background Featured Services What We Can Offer Application Why Choose Us FAQs Customer Review Related Services Contact Us
Introduction to Cell-based Antagonist Assay
Cell-based assays are essential tools in modern drug discovery, offering invaluable insights into cellular processes and drug mechanisms. Cell-based antagonist assays are crucial for identifying and characterizing compounds that inhibit cellular responses, paving the way for new therapeutic agents. Antagonists, which block agonist physiological effects, are fundamental to treating numerous diseases. Unlike binding assays, cell-based antagonist assays measure this inhibitory effect within a living cellular system, making them indispensable for drug discovery. They provide a more physiologically relevant assessment of a compound's ability to functionally inhibit cellular responses, thereby accelerating the identification of effective therapeutic antagonists.
Available Cell-based Antagonist Assays
Creative Biolabs offers a wide range of cell types for cell-based antagonist assays to meet the diverse needs of drug discovery projects. These include:
RAW 264.7 Cell-based Antagonist Assay
LX-2 Cell-based Antagonist Assay
Creative Biolabs offers the LX-2 cell-based antagonist assay to identify and evaluate hepatic fibrosis inhibitors. We use TGF-β1-induced LX-2 cells to quantify fibrogenic responses, assess compound efficacy on collagen and α-SMA expression, and elucidate antifibrotic mechanisms via high-throughput screening.
Learn More →Service Contents
Creative Biolabs offers a variety of cell-based antagonist assays tailored to meet the specific needs of our clients. Some of our primary services include:
Discover How We Can Help - Request a Consultation to Define Your Target-Specific Assay Strategy Today.
Application of Cell-based Antagonist Assays
Cell-based antagonist assays at Creative Biolabs are designed for a broad range of applications, including:
Why Choose Creative Biolabs?
Creative Biolabs offers unparalleled advantages for drug development, rooted in our expertise and next-generation assay technologies. Our advanced high-content screening (HCS) capabilities provide multiparametric, quantitative analysis of individual cell responses, detecting subtle functional changes and simultaneously tracking orthogonal readouts like IC50 measurements, cell viability, and morphology, while enabling subcellular targeting for receptor internalization and trafficking. We ensure guaranteed quality and reproducibility with clinically relevant cellular models, including 3D cell culture models for improved predictive value and primary cells for immune-oncology and inflammatory targets, ensuring near-physiological conditions. This holistic approach significantly de-risks your pipeline.
Experience the Creative Biolabs Advantage - Get a Quote Today and validate your next therapeutic breakthrough.
FAQs
What is the significance of using 3D cell culture models versus standard 2D monolayers?
Our assay offers significantly higher sensitivity and a superior signal-to-noise ratio, making it the preferred method for regulatory submission. It directly measures metabolically trapped substrate, which eliminates false positives and provides a more robust, quantitative measure of true transport kinetics.
How does Creative Biolabs handle potential cytotoxicity or false positives during screening?
Our use of the HCS platform is the primary solution. HCS performs multiparametric analysis, allowing us to simultaneously track the compound's antagonistic effect and its impact on cell viability and morphology.
Our lab currently uses a commercial kinetic binding assay. How do your cell-based assays compare in terms of throughput and cost?
While kinetic binding assays are valuable for affinity, they are not functional. Our cell-based assays are highly optimized for HTS using automated fluidics and plate readers, achieving comparable throughput but providing superior, functional data.
Customer Review
-
Validated Functional Efficacy
Using Creative Biolabs' services in our research has significantly facilitated the accurate functional classification of nAChR antagonists, allowing us to confidently advance our most potent leads while avoiding inactive binders. – Dr. L***n -
High-Content Mechanistic Detail
The integration of morphological and viability HCS readouts allowed us to confirm true antagonism while simultaneously monitoring compound toxicity, a distinct advantage over single-endpoint assays common in early screening. – E. M***z
Related Services
Achieving a validated lead often requires complementary expertise. We recommend the following services to support and expand your therapeutic development goals related to cell-based antagonist assay services:
Immune Cell Function Assay Services
Creative Biolabs offers comprehensive immune cell function assays to elucidate the capabilities of T, B, and NK cells, providing critical insights into immune responses and aiding in the development of next-generation immunotherapies.
Learn More →Dopamine Receptor Panel Screening Service
Creative Biolabs offers a dopamine receptor panel screening service for therapeutic antibody/protein discovery. We evaluate agonists/antagonists against receptors using stable cell lines, aiding in selective drug development for neurological disorders.
Learn More →Contact Us
Creative Biolabs is your strategic partner for cell-based antagonist assay services. We combine 20 years of biological expertise with the power of HCS and clinically relevant 3D models, ensuring your antagonist candidates are rigorously validated for functional efficacy. We deliver the robust, actionable scientific intelligence necessary to accelerate your drug discovery timeline and successfully advance novel therapeutics.
Contact Our Team for More Information and to Discuss Your Project
Download our brochureLoading case studies...
Online Inquiry